Venture studioJetpack Ventures is a venture studio based in the United States that funds and builds early-stage technology companies. They emphasize a hands-on approach to support innovative and disruptive startups.
Loading

Ampleia is a venture-building organization focused on supporting projects in rare disease therapeutics. They collaborate with scientists and entrepreneurs to develop therapeutic options for underserved indications.
Online destinations
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Destinations the organization presents as part of its public presence.
Ampleia is a venture studio founded in 2023 and based in Paris, France. It is dedicated to developing therapies for rare diseases by leveraging a vast network of over 6,000 medical and scientific experts. The organization aims to create companies that not only provide significant clinical benefits but also yield high financial returns, capitalizing on the unique economics of rare diseases.
Ampleia invests in the development of therapies for rare diseases, emphasizing high pricing per patient and a greater likelihood of success in clinical trials for orphan drugs. The organization believes that the economics of rare diseases are fundamentally different, leading to potentially significant returns on investment.
Ampleia offers a unique venture-building approach, combining scientific sourcing with execution-focused teams to advance programs from research into preclinical and clinical development. The organization provides access to a vast network of experts and resources within the AFM-Téléthon ecosystem.
Q: What is Ampleia's investment focus? A: Ampleia focuses on therapies for rare diseases. Q: How does Ampleia support startups? A: Ampleia provides access to a network of experts and resources to help advance therapeutic programs.
Superscout Pro

Superscout documents Ampleia independently from canonical records and linked sources. Missing facts stay missing.
Last reviewed .
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.